Sort
64,565 grants matching “drug discovery”
Mechanisms of naturally-acquired immunity to malaria and clinical trials of anti-malaria monoclonal antibodies
$2,825,052Peter Crompton · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Development of Specific Mu Opioid Receptor Antagonists to Reverse the Acute and Chronic Toxicity of Fentanyls
$2,824,374Yan Zhang · Virginia Commonwealth University · UG3 · FY2022 · DA
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
$2,823,010Daniel Ernest Ford · Johns Hopkins University · UL1 · FY2010 · RR
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
$2,823,009Daniel Ernest Ford · Johns Hopkins University · UL1 · FY2010 · RR
The University of Kansas Cancer Center
$2,822,506Roy A. Jensen · University Of Kansas Medical Center · P30 · FY2022 · CA
Genetic variant-based drug discovery targeting conserved pathways of aging
$2,822,483Jan No Middle Name Vijg · Albert Einstein College Of Medicine · U19 · FY2023 · AG
Scientific Core - Compound Optimization and Prioritization.
$2,822,282Anna Upton · Global Alliance For Tb Drug Development · U19 · FY2023 · AI
Institute for Clinical and Translational Science
$2,822,221Dan M Cooper · University Of California-Irvine · UL1 · FY2017 · TR
EMORY CHEMISTRY-BIOLOGY CENTER IN THE MLSCN(RMI)
$2,820,051Raymond J Dingledine · Emory University · U54 · FY2006 · HG
Targeting Cellular Senescence to Extend Healthspan
$2,819,749Sundeep Khosla · Mayo Clinic Rochester · P01 · FY2023 · AG
UCLA Center for Biological Radiation Mitigators
$2,819,495William H. McBride · University Of California Los Angeles · U19 · FY2013 · AI
Core F â High-Throughput Screening
$2,817,180Robert Marsden Cox · Emory University · U19 · FY2022 · AI
PHARMACOGENOMICS OF ARRHYTHMIA THERAPY
$2,815,099Vanderbilt University · U01 · FY2001 · HL
NOVEL THERAPEUTICS FOR PRION DISEASES
$2,813,128University Of California San Francisco · P01 · FY2003 · AG
Genomics of Acute Myelogenous Leukemia
$2,809,295Timothy J Ley · Washington University · P01 · FY2013 · CA
The University of Kansas Cancer Center
$2,808,770Roy A. Jensen · University Of Kansas Medical Center · P30 · FY2025 · CA
The University of Kansas Cancer Center
$2,808,765Roy A. Jensen · University Of Kansas Medical Center · P30 · FY2024 · CA
The University of Kansas Cancer Center
$2,808,760Roy A. Jensen · University Of Kansas Medical Center · P30 · FY2023 · CA
Collaboration on preclinical autism cellular assays, biosignatures, and network analyses (Copacabana)
$2,806,617Eugene Wei-Ming Yeo · University Of California, San Diego · U19 · FY2015 · MH
Atherosclerosis Intervention with Novel Tissue Selective Estrogen Complex Therapy
$2,803,461Howard N Hodis · University Of Southern California · R01 · FY2023 · AG
Targeting GPCRs in amygdalar and cortical neural ensembles to treat pain aversion
$2,802,899Gregory Scherrer · Univ Of North Carolina Chapel Hill · R01 · FY2020 · NS
The NIGMS Human Genetic Cell Repository Cooperative Agreement (U42) Application
$2,800,000Nahid Turan · Coriell Institute For Medical Research · U42 · FY2016 · GM
The NIGMS Human Genetic Cell Repository Cooperative Agreement (U42) Application
$2,800,000Deborah Requesens · Coriell Institute For Medical Research · U42 · FY2019 · GM
The NIGMS Human Genetic Cell Repository Cooperative Agreement (U42) Application
$2,800,000Nahid Turan · Coriell Institute For Medical Research · U42 · FY2017 · GM
The NIGMS Human Genetic Cell Repository Cooperative Agreement (U42) Application
$2,800,000Nahid Turan · Coriell Institute For Medical Research · U42 · FY2015 · GM